Literature DB >> 14504109

Constitutive mutants of the GM-CSF receptor reveal multiple pathways leading to myeloid cell survival, proliferation, and granulocyte-macrophage differentiation.

Anna L Brown1, Michelle Peters, Richard J D'Andrea, Thomas J Gonda.   

Abstract

Activation of the granulocyte-macrophage colony-stimulating factor (GM-CSF) family of receptors promotes the survival, proliferation, and differentiation of cells of the myeloid compartment. Several signaling pathways are activated downstream of the receptor, however it is not clear how these induce specific biologic outcomes. We have previously identified 2 classes of constitutively active mutants of the shared signaling subunit, human (h) betac, of the human GM-CSF/interleukin-3 (IL-3)/IL-5 receptors that exhibit different modes of signaling. In a factor-dependent bipotential myeloid cell line, FDB1, an activated mutant containing a substitution in the transmembrane domain (V449E) induces factor-independent proliferation and survival, while mutants in the extracellular domain induce factor-independent granulocyte-macrophage differentiation. Here we have used further mutational analysis to demonstrate that there are nonredundant functions for several regions of the cytoplasmic domain with regard to mediating proliferation, viability, and differentiation, which have not been revealed by previous studies with the wild-type GM-CSF receptor. This unique lack of redundancy has revealed an association of a conserved membrane-proximal region with viability signaling and a critical but distinct role for tyrosine 577 in the activities of each class of mutant.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504109     DOI: 10.1182/blood-2003-05-1435

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Crossing paths: interactions between the cell death machinery and growth factor survival signals.

Authors:  Gabriela Brumatti; Marika Salmanidis; Paul G Ekert
Journal:  Cell Mol Life Sci       Date:  2010-02-16       Impact factor: 9.261

2.  Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit.

Authors:  Michelle Perugini; Anna L Brown; Diana G Salerno; Grant W Booker; Cvetan Stojkoski; Timothy R Hercus; Angel F Lopez; Margaret L Hibbs; Thomas J Gonda; Richard J D'Andrea
Journal:  Blood       Date:  2010-02-19       Impact factor: 22.113

Review 3.  The colony-stimulating factors and cancer.

Authors:  Donald Metcalf
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

4.  The GM-CSF receptor utilizes β-catenin and Tcf4 to specify macrophage lineage differentiation.

Authors:  Anna L Brown; Diana G Salerno; Teresa Sadras; Grant A Engler; Chung H Kok; Christopher R Wilkinson; Saumya E Samaraweera; Timothy J Sadlon; Michelle Perugini; Ian D Lewis; Thomas J Gonda; Richard J D'Andrea
Journal:  Differentiation       Date:  2011-10-08       Impact factor: 3.880

5.  The Human Pseudoautosomal Region (PAR): Origin, Function and Future.

Authors:  A Helena Mangs; Brian J Morris
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

6.  Peroxisome proliferator-activated receptor-gamma regulates the expression of alveolar macrophage macrophage colony-stimulating factor.

Authors:  Tracey L Bonfield; Mary Jane Thomassen; Carol F Farver; Susamma Abraham; Mary T Koloze; Xia Zhang; David M Mosser; Daniel A Culver
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 7.  Macrophages as a Source and Recipient of Wnt Signals.

Authors:  Elizabeth S Malsin; Seokjo Kim; Anna P Lam; Cara J Gottardi
Journal:  Front Immunol       Date:  2019-07-31       Impact factor: 7.561

8.  Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity.

Authors:  S Weng; S Matsuura; C T Mowery; S A Stoner; K Lam; D Ran; A G Davis; M-C Lo; D-E Zhang
Journal:  Leukemia       Date:  2016-06-15       Impact factor: 11.528

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.